Superficial Radiotherapy (SRT)

Skin Can­cer

Each year, near­ly four mil­lion peo­ple in the Unit­ed States are diag­nosed with basal and squa­mous cell car­ci­no­ma, also known as non-melanoma skin can­cer. Super­fi­cial Radio­ther­a­py (SRT) is non-sur­gi­cal treat­ment deliv­ers a remark­able cure rate of 95% for non-melanoma skin can­cer. Per­formed right in our office, each treat­ment is pain­less and only takes a few min­utes. The SRT-100™can be used to treat lesions on the arms, legs, back, and trunk. It works espe­cial­ly well on skin can­cers locat­ed on the head and neck where near­ly 80 per­cent of all skin can­cer occurs — espe­cial­ly along the fold of the nose, eye­lids, lips, cor­ner of the mouth and the lin­ing of the ear. And because the treat­ment doesn’t require cut­ting, stitch­ing or scar­ring, there’s no need for recon­struc­tive plas­tic surgery after the treatment.

Keloid Scars

The SRT-100™ by Sen­sus Health­care is giv­ing count­less keloid suf­fer­ers new hope and con­fi­dence. Whether you suf­fer from keloids caused by surgery, acne, chick­en­pox, pierc­ing or burns, the SRT-100™ effec­tive­ly destroys these non-malig­nant tumors caused by skin trau­ma. The SRT-100™ is also a good treat­ment option for indi­vid­u­als who are genet­i­cal­ly prone to keloids — includ­ing African Amer­i­cans, Lati­nos, and Asians. In fact, patients of all skin types who under­go quick and pain­less treat­ment with the SRT-100™ enjoy cure rates of 90 per­cent and higher.

To learn more about SRT, call Quin­cy Med­ical Group’s Der­ma­tol­ogy Depart­ment at (217) 222‑6550, ext. 3435.

Learn More About QMG Der­ma­tol­ogy Services